Regular ArticleSurvivin expression in human osteosarcoma is a marker for survival
References (11)
Murai Y, Matsui K. Survivin expression in tumor cells nuclei is predictive of a favorable prognosis in gastric cancer patients
Cancer Res
(2001)- et al.
Tumor size and prognosis in aggressively treated osteosarcoma
J Clin Oncol
(1996) - et al.
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Nat Med
(1997) - et al.
Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
Cancer Res
(1998) - et al.
Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients
Int J Cancer
(2001)
Cited by (114)
A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy
2021, Cellular and Molecular Gastroenterology and HepatologyImmunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma
2017, Journal of Comparative PathologyCitation Excerpt :Detection of specific tumour markers in OS is important for accurate diagnosis, prediction of prognosis, metastases and response to chemotherapy (Selvarajah and Kirpensteijn, 2010). Despite the aetiology of OS being complex, some tumour markers are expressed at low levels or are overexpressed in canine and human OS (Trieb et al., 2003; Barger et al., 2005; Won et al., 2009). Tumour markers that are generally expressed in human OS include vimentin, S100, osteonectin, osteocalcin, smooth muscle actin (SMA), CD99 and neuron-specific enolase (NSE) (Trihia and Valavanis, 2012).
A sandwich-type DNA biosensor based on electrochemical co-reduction synthesis of graphene-three dimensional nanostructure gold nanocomposite films
2013, Analytica Chimica ActaCitation Excerpt :It has been considered to be an important factor that provides potent resistance against chemotherapeutic drugs [39]. Recent studies have demonstrated that survivin is correlated with osteosarcoma and could be used as a molecular marker for prognosis of osteosarcoma [40,41]. The reported techniques for gene detection included flow cytometry (FCM) [42], fluorescence in situ hybridization (FISH) [43], chromosome analysis [44], real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) [45].
Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
2022, International Journal of Molecular Sciences
- f1
Correspondence to: Prof. Dr Klemens Trieb, Department of Orthopaedics, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel: +43-1-40400-4070; Fax: +43-1-40400-4077; E-mail:[email protected]